Published in Br J Psychiatry on September 01, 1996
Psychomotor retardation in depression: a systematic review of diagnostic, pathophysiologic, and therapeutic implications. Biomed Res Int (2013) 1.01
Predictors of response to electro-convulsive therapy in major depression. Indian J Psychiatry (2000) 0.78
Predictors of the short-term responder rate of Electroconvulsive therapy in depressive disorders--a population based study. BMC Psychiatry (2012) 0.78
Clinical variables as predictors of response to electroconvulsive therapy in endogenous depression. Indian J Psychiatry (2000) 0.77
Symptom predictors of response to electroconvulsive therapy in older patients with treatment-resistant depression. Int J Gen Med (2011) 0.77
Who responds to electroconvulsive therapy? Br J Psychiatry (1996) 0.75
A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology (2007) 5.86
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA (2001) 4.34
Physical properties and quantification of the ECT stimulus: I. Basic principles. Convuls Ther (1994) 4.18
Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. Brain Stimul (2008) 3.50
Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med (1993) 3.45
Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Arch Gen Psychiatry (2006) 3.44
A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry (2000) 3.06
Cardiovascular complications of ECT in depressed patients with cardiac disease. Am J Psychiatry (1993) 2.80
Functional deficits in patients with mild cognitive impairment: prediction of AD. Neurology (2002) 2.79
Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. Arch Gen Psychiatry (2003) 2.70
Psychomotor symptoms of depression. Am J Psychiatry (1997) 2.45
Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry (1996) 2.32
Titrated moderately suprathreshold vs fixed high-dose right unilateral electroconvulsive therapy: acute antidepressant and cognitive effects. Arch Gen Psychiatry (2000) 2.30
Memory and ECT: from polarization to reconciliation. J ECT (2000) 2.18
Electro-convulsive therapy practices in the community. Psychol Med (2001) 2.15
Electroconvulsive therapy of acute manic episodes: a review of 50 years' experience. Am J Psychiatry (1994) 2.12
The effects of electroconvulsive therapy on memory of autobiographical and public events. Arch Gen Psychiatry (2000) 1.91
Subjective memory complaints: a review of patient self-assessment of memory after electroconvulsive therapy. J ECT (2000) 1.89
Strengthening clinical effectiveness trials: equipoise-stratified randomization. Biol Psychiatry (2001) 1.88
A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease. Am J Psychiatry (1998) 1.85
The Texas Medication Algorithm Project: report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder. J Clin Psychiatry (1999) 1.84
Neuropsychological dysfunction in depressed suicide attempters. Am J Psychiatry (2001) 1.80
Does ECT alter brain structure? Am J Psychiatry (1994) 1.78
Functional significance of mild cognitive impairment in elderly patients without a dementia diagnosis. Am J Geriatr Psychiatry (1999) 1.77
Sham TMS: intracerebral measurement of the induced electrical field and the induction of motor-evoked potentials. Biol Psychiatry (2001) 1.74
The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol (1990) 1.71
Vagus nerve stimulation: a new tool for brain research and therapy. Biol Psychiatry (2000) 1.69
Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study. Biol Psychiatry (2000) 1.61
Treatment of the modal patient: does one size fit nearly all? J ECT (2001) 1.61
Determinants of seizure threshold in ECT: benzodiazepine use, anesthetic dosage, and other factors. J ECT (2000) 1.56
The effects of electroconvulsive therapy on quantitative electroencephalograms. Relationship to clinical outcome. Arch Gen Psychiatry (1996) 1.53
Functional impairment in elderly patients with mild cognitive impairment and mild Alzheimer disease. Arch Gen Psychiatry (2011) 1.50
Regional cerebral blood flow in mood disorders. II. Comparison of major depression and Alzheimer's disease. J Nucl Med (1993) 1.45
Regional cerebral blood flow in mood disorders, V.: Effects of antidepressant medication in late-life depression. Am J Geriatr Psychiatry (2000) 1.44
Low use of neuroleptic drugs in the treatment of psychotic major depression. Am J Psychiatry (1997) 1.44
Quantitative EEG during seizures induced by electroconvulsive therapy: relations to treatment modality and clinical features. I. Global analyses. J ECT (2000) 1.44
Hemispheric asymmetry in the expression of positive and negative emotions. Neurologic evidence. Arch Neurol (1982) 1.43
A 10-item smell identification scale related to risk for Alzheimer's disease. Ann Neurol (2005) 1.42
Does ECT permanently alter seizure threshold? Biol Psychiatry (1993) 1.41
Transcranial magnetic stimulation: applications in neuropsychiatry. Arch Gen Psychiatry (1999) 1.38
Prolactin response to electroconvulsive therapy: effects of electrode placement and stimulus dosage. Biol Psychiatry (1998) 1.38
A unilateral, prolonged, nonconvulsive seizure in a patient treated with bilateral ECT. J ECT (2001) 1.38
Predictors of retrograde amnesia following ECT. Am J Psychiatry (1995) 1.35
Decreased regional brain metabolism after ect. Am J Psychiatry (2001) 1.33
Medication resistance and clinical response to electroconvulsive therapy. Psychiatry Res (1990) 1.32
Emotions are expressed more intensely on the left side of the face. Science (1978) 1.31
Citalopram for agitation in Alzheimer's disease: design and methods. Alzheimers Dement (2012) 1.31
Different brain networks mediate task performance in normal aging and AD: defining compensation. Neurology (2000) 1.28
Stimulus intensity, seizure threshold, and seizure duration: impact on the efficacy and safety of electroconvulsive therapy. Psychiatr Clin North Am (1991) 1.27
Olfactory dysfunction as a predictor of neurodegenerative disease. Curr Neurol Neurosci Rep (2006) 1.26
Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease. Neurology (2002) 1.25
Change in cognitive functioning following acute antidepressant treatment in late-life depression. Am J Geriatr Psychiatry (2009) 1.23
Magnetic seizure therapy of major depression. Arch Gen Psychiatry (2001) 1.22
Studies of dosage, seizure threshold, and seizure duration in ECT. Biol Psychiatry (1987) 1.20
Inadequacy of antidepressant treatment for patients with major depression who are at risk for suicidal behavior. Am J Psychiatry (1999) 1.14
Psychopathological features in Alzheimer's disease: course and relationship with cognitive status. J Am Geriatr Soc (2003) 1.12
Cerebral perfusion as a diagnostic marker of early Alzheimer's disease. Neurology (1988) 1.10
Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat. J Pharmacol Exp Ther (1984) 1.06
Use of ECT for the inpatient treatment of recurrent major depression. Am J Psychiatry (1998) 1.03
ECT in bipolar and unipolar depression: differences in speed of response. Bipolar Disord (2001) 1.03
Acute efficacy of ECT in the treatment of major depression in the old-old. Am J Psychiatry (1999) 1.03
Deliberate seizure induction with repetitive transcranial magnetic stimulation in nonhuman primates. Arch Gen Psychiatry (2001) 1.02
Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study. Int J Geriatr Psychiatry (2008) 1.01
Anticonvulsant and antidepressant properties of electroconvulsive therapy: a proposed mechanism of action. Biol Psychiatry (1983) 0.99
Regional cerebral blood flow in mood disorders. I. Comparison of major depressives and normal controls at rest. Arch Gen Psychiatry (1990) 0.98
Continuation ECT in treatment-resistant schizophrenia: a controlled study. J ECT (1999) 0.98
Behavioral syndromes in Alzheimer's disease. Int Psychogeriatr (1992) 0.97